enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Desmopressin - Wikipedia

    en.wikipedia.org/wiki/Desmopressin

    Desmopressin (1-deamino-8-D-arginine vasopressin) is a synthetic form of the normal human hormone arginine vasopressin (the antidiuretic hormone, or ADH), a peptide containing nine amino acids. Compared to vasopressin, desmopressin's first amino acid has been deaminated , and the arginine at the eighth position is in the dextro rather than the ...

  3. Vasopressin analogue - Wikipedia

    en.wikipedia.org/wiki/Vasopressin_analogue

    Vasopressin analogues are synthetic peptides structurally and functionally similar to arginine vasopressin (AVP), a naturally occurring hormone in mammals. These compounds have been developed to target specific vasopressin receptors ( V1 , V2 , and V3 ) with varying affinities, allowing for more tailored therapeutic applications.

  4. Vasopressin (medication) - Wikipedia

    en.wikipedia.org/wiki/Vasopressin_(medication)

    Vasopressin agonists are used therapeutically in various conditions, and its long-acting synthetic analogue desmopressin is used in conditions featuring low vasopressin secretion, as well as for control of bleeding (in some forms of von Willebrand disease and in mild haemophilia A) and in extreme cases of bedwetting by children.

  5. AOL latest headlines, entertainment, sports, articles for business, health and world news.

  6. Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.

  7. Central diabetes insipidus - Wikipedia

    en.wikipedia.org/wiki/Central_diabetes_insipidus

    Central diabetes insipidus, recently renamed arginine vasopressin deficiency (AVP-D), [1] is a form of diabetes insipidus that is due to a lack of vasopressin (ADH) production in the brain. Vasopressin acts to increase the volume of blood (intravascularly), and decrease the volume of urine produced.

  8. US FDA approves Mesoblast's cell therapy for graft-versus ...

    www.aol.com/news/us-fda-approves-mesoblasts-cell...

    News. Science & Tech. Shopping. Sports. Weather. US FDA approves Mesoblast's cell therapy for graft-versus-host disease. December 18, 2024 at 4:57 PM

  9. ESPN Announcer Dick Vitale Says He Has 'Lots of Anxiety' as ...

    www.aol.com/espn-announcer-dick-vitale-says...

    Related: Dick Vitale Says His Vocal Cord Cancer Is ‘Gone’ but Will Wait to Return to ESPN Broadcasting Job In a Dec. 5 update, Vitale said, “I feel terrific but have lots of anxiety about ...